{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:57:53Z","timestamp":1788001073957,"version":"build-2784847793"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Patients with pulmonary hypertension associated with a left-right shunt include a wide spectrum of pathophysiological substrates, ranging from those characterized by pulmonary over-circulation to those with advanced pulmonary vascular disease. The former group may benefit from shunt repair in carefully selected cases but, when advanced pulmonary vascular disease has developed, defect closure should be avoided, and pulmonary vasodilators may be used to improve effort tolerance and hemodynamics. There is a paucity of evidence, however, to support decision-making in the care of these patients. We discuss the principles of management in patients with pulmonary hypertension and a predominant left-right shunt. The recommendations and statements made in this paper are based on pathophysiological considerations and expert opinion.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1360555","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:31:08Z","timestamp":1715229068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary arterial hypertension related to congenital heart disease with a left-to-right shunt: phenotypic spectrum and approach to management"],"prefix":"10.3389","volume":"11","author":[{"given":"Paolo","family":"Ferrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ijcard.2012.02.007","article-title":"Disease targeting therapies in patients with eisenmenger syndrome: response to treatment and long-term efficiency","volume":"167","author":"Diller","year":"2013","journal-title":"Int J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan\u2013sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and eisenmenger physiology","volume":"155","author":"D\u2019Alto","year":"2012","journal-title":"Int J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2014.04.072","article-title":"Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification","volume":"174","author":"van Riel","year":"2014","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/jcm9051456","article-title":"Pulmonary hypertension in adults with congenital heart disease: real-world data from the international COMPERA-CHD registry","volume":"9","author":"Kaemmerer","year":"2020","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/bmj.2.5099.755","article-title":"The eisenmenger syndrome or pulmonary hypertension with reversed central shunt","volume":"2","author":"Wood","year":"1958","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ijcard.2014.11.100","article-title":"Physiological differences between various types of eisenmenger syndrome and relation to outcome","volume":"179","author":"Moceri","year":"2015","journal-title":"Int J Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1711660216","article-title":"Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodelling studied in lung biopsies","volume":"166","author":"Hall","year":"1992","journal-title":"J Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/humu.22904","article-title":"Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects","volume":"36","author":"Machado","year":"2015","journal-title":"Hum Mutat"},{"key":"B17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur Respir J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.3390\/ijms231810433","article-title":"Clinical implications of the genetic background in pediatric pulmonary arterial hypertension: data from the spanish REHIPED registry","volume":"23","author":"Cruz-Utrilla","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2200656","DOI":"10.1183\/13993003.00656-2022","article-title":"An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants","volume":"60","author":"Montani","year":"2022","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1801965","DOI":"10.1183\/13993003.01965-2018","article-title":"Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension","volume":"54","author":"Galambos","year":"2019","journal-title":"Eur Respir J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e8681761","DOI":"10.1155\/2020\/8681761","article-title":"Atrial septal defect with eisenmenger syndrome: a rare presentation","volume":"2020","author":"Forlemu","year":"2020","journal-title":"Case Rep Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8901","DOI":"10.3390\/ijms21238901","article-title":"Epigenetic regulation of pulmonary arterial hypertension-induced vascular and right ventricular remodeling: new opportunities?","volume":"21","author":"Kocken","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12931-022-02137-z","article-title":"Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension","volume":"23","author":"Zhou","year":"2022","journal-title":"Respir Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-5223(19)38415-6","article-title":"Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery","volume":"87","author":"Wagenvoort","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/eurheartj\/9.suppl_J.7","article-title":"Morphological substrate for the reversibility and irreversibility of pulmonary hypertension","volume":"9","author":"Wagenvoort","year":"1988","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e008587","DOI":"10.1161\/JAHA.118.008587","article-title":"Definition and management of segmental pulmonary hypertension","volume":"7","author":"Dimopoulos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/s0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2102419","DOI":"10.1183\/13993003.02419-2021","article-title":"External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension registry","volume":"59","author":"Boucly","year":"2021","journal-title":"Eur Respir J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2008.02.004","article-title":"Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy","volume":"129","author":"Dimopoulos","year":"2008","journal-title":"Int J Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/heartjnl-2023-323015","article-title":"Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease","volume":"110","author":"Luna-Lopez","year":"2024","journal-title":"Heart"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1901401","DOI":"10.1183\/13993003.01401-2019","article-title":"The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in eisenmenger syndrome","volume":"54","author":"D\u2019Alto","year":"2019","journal-title":"Eur Respir J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/yty033","article-title":"Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series","volume":"2","author":"Akagi","year":"2018","journal-title":"Eur Heart J Case Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.amjcard.2021.01.025","article-title":"Transcatheter closure of atrial septal defect associated with pulmonary artery hypertension using fenestrated devices","volume":"147","author":"Wang","year":"2021","journal-title":"Am J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jocs.12325","article-title":"Repair of ventricular septal defect with eisenmenger syndrome after bosentan treatment","volume":"29","author":"Hu","year":"2014","journal-title":"J Card Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12872-020-01795-5","article-title":"Transcatheter closure for patent ductus arteriosus in patients with eisenmenger syndrome: to do or not?","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1161\/CIR.0000000000000602","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Stout","year":"2018","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"204589402091788","DOI":"10.1177\/2045894020917885","article-title":"\u201cTreat and repair\u201d strategy for shunt lesions: a critical review","volume":"10","author":"Arvind","year":"2020","journal-title":"Pulm Circ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijcard.2020.05.086","article-title":"Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (Taiwan congenital heart disease associated with pulmonary arterial hypertension) registry","volume":"317","author":"Chiu","year":"2020","journal-title":"Int J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1086\/681269","article-title":"Selective pulmonary vasodilation improves ventriculovascular coupling and gas exchange in a patient with unrepaired single-ventricle physiology","volume":"5","author":"Rischard","year":"2015","journal-title":"Pulm Circ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1183\/09031936.00217911","article-title":"Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension","volume":"40","author":"Deboeck","year":"2012","journal-title":"Eur Respir J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.healun.2018.11.015","article-title":"The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension","volume":"38","author":"Badagliacca","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1161\/circulationaha.105.594218","article-title":"Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival","volume":"113","author":"Dimopoulos","year":"2006","journal-title":"Circulation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1360555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:31:10Z","timestamp":1715229070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1360555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":49,"alternative-id":["10.3389\/fcvm.2024.1360555"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1360555","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"article-number":"1360555"}}